Can Hyperbaric Oxygen Actually Slow Biological Aging?

We were all taught the same story about aging. It only moves one direction. You manage it, you slow it a little with sleep and exercise, but you never move the needle backward. A group of trials out of Tel Aviv is starting to complicate that story, and the data deserves a clear-eyed look, without the longevity-industry hype that usually surrounds it.

Start with what aging actually is at the cellular level. Two of the most established markers scientists use are telomere length and cellular senescence. Telomeres are the protective caps on the ends of your chromosomes. Every time a cell divides, they get a little shorter, and short telomeres track with age-related disease. Senescent cells are the second marker. These are old cells that have stopped dividing but refuse to die. They sit in your tissue and leak inflammatory signals into everything around them. If you want a mental picture of what “getting older” looks like inside the body, it is shortening telomeres and a rising load of these inflammatory zombie cells.

Here is what the researchers did. They took 35 healthy adults aged 64 and older, people with no cognitive or physical decline, and put them through 60 daily hyperbaric oxygen sessions over three months. Each session was 100% oxygen at two atmospheres of pressure for 90 minutes, with short air breaks built in. Then they measured those two aging markers in the participants’ immune cells.

The results went the opposite direction of normal aging. Telomere length increased significantly, by roughly 38% in B cells, about 29% in T helper cells, and around 22% in natural killer cells (Hachmo et al., Aging (Albany NY), 2020). The population of senescent T helper cells dropped by about 37%. A separate trial from the same group looked at skin and found increased collagen density, new blood vessel formation, and fragmented elastic fibers being replaced with longer, healthier ones (Hachmo et al., Aging, 2021).

The mechanism has a name, and it is worth understanding because it is counterintuitive. It is called the hyperoxic-hypoxic paradox. You flood the tissue with a high concentration of oxygen during the session, then the level drops back to normal when the session ends. The body reads that swing as a low-oxygen stress event, even though it is the opposite, and it launches a regenerative response normally reserved for genuine oxygen deprivation. That response includes stem cell proliferation, new blood vessel growth, mitochondrial repair, and the activation of longevity-associated pathways. In other words, the therapy works by fooling the body’s own repair machinery into turning on.

But here is why it matters for the people we work with. Veterans and first responders often carry bodies that have aged faster than the calendar says they should have. Years of physical load, blast exposure, broken sleep, and chronic inflammation add up. For that population, the idea that a measurable marker of biological aging can move at all reframes the whole conversation. Aging stops looking like a fixed sentence and starts looking like a process, at least in part.

The question is not whether we can live forever. The question is narrower and more useful. Is the pace of biological aging more changeable than we assumed? The early answer is maybe, and that alone is worth watching closely while better-controlled trials do the real work of finding out.